Personalised Therapeutics @ LUMC
Recruiting
- Conditions
- Geen specifieke aandoening, patienten worden voor een geplande opname geïncludeerdn.v.t.
- Registration Number
- NL-OMON54078
- Lead Sponsor
- eids Universitair Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 1000
Inclusion Criteria
Provision of informed consent (IC) prior to any study specific procedures.
Be aged >=18
Is able to provide a blood sample via venapunction
Receive a medication verification interview
Be able and willing to be followed-up for at least one year
Exclusion Criteria
Pregnancy or lactating
Previous participation in the PREPARE trial (NCT03093818, NL60069.058.16)
History of a liver transplantation or stem-cel transplantation
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary outcome is the occurrence of drug-genotype associated adverse drug<br /><br>reactions (ADR) in the first 12 months following the genetic test. The outcome<br /><br>is dichotomized at >= grade 3 CTC-AE. </p><br>
- Secondary Outcome Measures
Name Time Method